Abstract
The pediatric patient may present with a variety of dermatoses that either involve the eye primarily or are secondary to a more generalized process. The oculoplastic surgeon should become familiar with disorders occurring in and around the eye that are benign or may herald an underlying dermatologic disorder.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Osburn K, Schosser RH, Everett MA. Congenital pigmented and vascular lesions in newborn infants. J Am Acad Dermatol. 1987;16:788–92.
Lorentzen M, Pers M, Brettville JG. The incidence of malignant transformation in giant pigmented nevi. Scand J Plast Reconstr Surg. 1977;11:163–7.
Quaba AA, Wallace AF. Incidence of malignant melanoma rising in large congenital nevocellular nevi. Plast Reconst Surg. 1986;78:174–87.
Charbel C, Fontaine RH, Malouf GG, et al. NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi. J Invest Dermatol. 2014;134:1067–74.
Roh MR, Eliades P, Gupta S, Tsao H. Genetics of melanocytic nevi. Pigment Cell Melanoma Res. 2015;28(6):661–72.
Illig L, Weidner F, Hundeiker M, et al. Congenital nevi less than 10 cm as precursors to melanoma. Arch Dermatol. 1985;121:1274–81.
McDonnell PJ, Mayou B. Congenital divided nevus of the eyelids. Br J Ophthalmol. 1988;72:198–201.
Van Raamsdonk CD, Fitch KR, Fuchs H, et al. Effects of G-protein mutations on skin color. Nat Genet. 2004;36(9):961–8.
Teekhasaenee C, Ritch R, Rutnin U, et al. Ocular findings in oculodermal melanocytosis. Arch Ophthalmol. 1990;108:1114–20.
Hidano A, Kajima H, Ikeda S, et al. Natural history of nevus of Ota. Arch Dermatol. 1967;85:187–95.
Jay B. Malignant melanoma of the orbit in a case of oculodermal melanocytosis (nevus of Ota). Br J Ophthalmol. 1965;49:359.
Dutton JJ, Anderson RL, Schelper RL, et al. Orbital malignant melanoma and oculodermal melanocytosis: report of 2 cases and review of the literature. Ophthalmology. 1984;91:497–507.
Sang DN, Albert DM, Sober AJ. Nevus of Ota with contralateral cerebral melanoma. Ophthalmology. 1985;20:176–8.
Levin MK, Ng E, Bae YS, et al. Treatment of pigmentary disorders in patients with skin of color with a novel 755 nm picosecond, Q-switched ruby, and Q-switched Nd:YAG nanosecond lasers: a retrospective photographic review. Lasers Surg Med. 2016;48(2):181–7.
Stanford DG, Hart R, Thompson JF. Ocular melanoma in childhood. Aust NZ J Surg. 1993;63:729–31.
Vivian AJ, Ellison DW, McGill JI. Ocular melanomas in xeroderma pigmentosum. Br J Ophthalmol. 1993;77(9):597–8.
Bataille V, Sasieni P, Cuzick J, et al. Risk of ocular melanoma in relation to cutaneous and iris naevi. Int J Cancer. 1995;60(5):622–6.
Sheilds CL, Kaliki S, Livesey M, et al. Association of ocular and oculodermal melanocytosis with the rate of uveal melanoma metastasis: analysis of 7872 consecutive eyes. JAMA Ophthalmol. 2013;131(8):993–1003.
Broadway D, Lang S, Harper J, et al. Congenital malignant melanoma of the eye. Cancer. 1991;67:2642–52.
Greer CH. Congenital melanoma of the anterior uvea. Arch Ophthalmol. 1966;76(1):77–8.
Colenbrander MC. A cystic eye with a congenital melanoma. Ophthalmologica. 1968;156(1):83–5.
Paller AS, Pensler JM, Tomita T. Nasal midline masses in infants and children: dermoids, encephaloceles, and gliomas. Arch Dermatol. 1991;127:362–6.
Murray JE, Cannon B. Basal-cell cancer in children and young adults. N Engl J Med. 1960;262:440.
Stein HL, Webster GV. Basal cell carcinoma in children. Am J Surg. 1958;96:445.
Milstone EB, Helwig EB. Basal cell carcinoma in children. Arch Dermatol. 1973;108:523–7.
Comstock J, Hansen RC, Korc A. Basal cell carcinoma in a 12-year-old boy. Pediatrics. 1990;86:460–3.
Ledwig PA, Paller AS. Congenital basal cell carcinoma. Arch Dermatol. 1991;127:1066–7.
Khosravi H, Schmidt B, Huang JT. Characteristics and outcomes of nonmelanoma skin cancer (NMSC) in children and young adults. J Am Acad Dermatol. 2015;73(5):785–90.
Bauland CG, Lüning TH, Smit JM, et al. Untreated hemangiomas: growth pattern and residual lesions. Plast Reconstr Surg. 2011;127(4):1643–8.
Storch C, Hoeger PH. Propranolol for infantile haemangiomas: insights in to the molecular mechanisms of action. Br J Dermatol. 2010;163(2):269–74.
Hemangeol prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205410s000lbl.pdf. Last accessed 8 Aug 2016.
Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015;372(8):735–46.
Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358(24):2649–51.
Abarzúa-Araya A, Avarrete-Dechent CP, Heusser F, et al. Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study. J Am Acad Dermatol. 2014;70(6):1045–9.
Randhawa HK, Sibbald C, Garcia Romero MT, Pope E. Oral nadolol for the treatment of infantile hemangiomas: a single-institution retrospective cohort study. Pediatr Dermatol. 2015;32(5):690–5.
Scheck O, Horny HP, Ruck P, et al. Solitary mastocytoma of the eyelid: a case report with special reference to the immunocytology of human tissue mast cells, and a review of the literature. Virchows Arch. 1987;412:31–6.
Naysan J, Kodsi SR, Kristal L. Solitary mastocytoma of the eyelid. J AAPOS. 2013;17(4):443–4.
Ma SP, Hardy TG. Solitary mastocytoma of the eyelid in an adult patient with prolidase deficiency. Ophthal Plast Reconstr Surg. 2015;33(1):e10–3.
Hughes GB, Shapiro G, Hunt W, et al. Management of the congenital midline nasal masses: a review. Head Neck Surg. 1980;2:222–3.
Whitaker SR, Sprinkle PM, Chou SM. Nasal glioma. Arch Otolaryngol. 1981;107:550–4.
Thompson HG, Al-Qattan MM, Becker LE. Nasal glioma: Is dermis involvement significant? Ann Plast Surg. 1995;34:168–72.
Levine MR, Kellis A, Lash R. Nasal glioma masquerading as a capillary hemangioma. Ophthal Plast Reconstr Surg. 1993;9:132–4.
Kennard CD, Rasmussen JE. Congenital midline nasal masses: diagnosis and management. J Dermatol Surg Oncol. 1990;16:1025–36.
Boniuk M, Zimmerman LE. Pilomatrixoma (benign calcifying epithelioma) of the eyelids and eyebrows. Arch Ophthalmol. 1963;70:399–406.
O'Grady RB, Spoerl G. Pilomatrixoma (benign calcifying epithelioma of Malherbe). Ophthalmology. 1981;88:1196–7.
Friedman AH, Henkind P. Granuloma pyogenicum of the palpebral conjunctiva. Am J Ophthalmol. 1971;71:868–72.
Duke-Elder S. Textbook of Ophthalmology, vol. 5. London: Kimpton; 1952. p. 4839.
Sen DK. Granuloma pyogenicum of the palpebral conjunctiva. J Pediatr Ophthalmol Strabismus. 1982;19:112–4.
Ferry AP, Zimmerman LE. Granuloma pyogenicum of limbus simulating recurrent squamous cell carcinoma. Arch Ophthalmol. 1965;74:229–30.
Mohan H, Gupta AN. Granuloma pyogenicum. Am J Ophthalmol. 1968;65:619–20.
Asiyo MN, Stefani FH. Pyogenic granulomas of the lacrimal sac. Eye. 1992;6:97–101.
Minckler D. Pyogenic granuloma of the cornea simulating squamous cell carcinoma. Arch Ophthalmol. 1979;97:516–7.
Ferry AP. Pyogenic granulomas of the eye and ocular adnexa: a study of 100 cases. Trans Am Ophthalmol Soc. 1989;87:327–47.
Hertle RW, Durso F, Metzler JP, et al. Epibulbar squamous cell carcinomas in brothers with xeroderma pigmentosa. J Pediatr Ophthalmol Strabismus. 1991;28:350–3.
Butterworth T, Strean LP, Beerman H, et al. Syringoma and mongolism. Arch Dermatol. 1964;90:483–7.
Haber C, Kwiterovich PO Jr. Dyslipoproteinemia and xanthomatosis. Pediatr Dermatol. 1984;1:261–80.
Ozcelik U, Dogru D, Akcoren Z, et al. Xanthoma disseminatum: a child with respiratory system involvement and bronchiectasis. Pediatr Pulmonol. 2005;39(1):84–7.
Or L, Eviatar JA, Massry GG. Xanthelasma-like reaction to filler injections. Ophthal Plast Reconstr Surg. 2016. [Epub ahead of print].
Rigopoulos D, Prantsidis A, Christofidou E, et al. Pimecrolimus 1% cream in the treatment of disseminated granuloma annulare. Br J Dermatol. 2005 Jun;152(6):1364–5.
Jain S, Stephens CJ. Successful treatment of disseminated granuloma annulare with topical tacrolimus. Br J Dermatol. 2004;150(5):1042–3.
Blank H, Eglick JG, Beerman H. Nevoxanthoendothelioma with ocular involvement. Pediatrics. 1949;4:349–54.
Schwartz TL, Carter KD, Judisch GF, et al. Congenital macronodular juvenile xanthogranuloma of the eyelid. Ophthalmology. 1991;98:1230–3.
Zimmerman LE. Ocular lesions of juvenile xanthogranuloma: nevoxanthoendothelioma. Trans Am Acad Ophthalmol Otolaryngol. 1965;69:412–42.
Sanders TE. Intraocular juvenile xanthogranuloma. Am J Ophthalmol. 1962;53:455.
Brenkman RF, Oosterhuis JA, Manschot WA. Recurrent hemorrhage in the anterior chamber caused by a (juvenile) xanthogranuloma of the iris in an adult. Doc Ophthalmol. 1977;42:329–33.
Gorlin RJ, Goltz RW. Multiple nevoid basal cell epithelioma, jaw cysts and bifid rib syndrome. N Engl J Med. 1960;262:908–12.
Gorlin RJ. Nevoid basal cell carcinoma syndrome. Medicine (Baltimore). 1987;66:99–109.
Evans DGR, Ladusans EJ, Rimmer S, et al. Complications of the naevoid basal cell carcinoma syndrome: results of a population based study. J Med Genet. 1993;30:460–4.
Insler MI, Davlin L. Ocular findings in linear sebaceous nevus syndrome. Br J Ophthalmol. 1987;71:268–72.
Ho VCY, McLean D. Epidermal nevus syndrome. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg M, Austen KF, editors. Dermatology in general Medicine. New York: McGraw-Hill; 1993. p. 863–5.
Lim YH, Ovejero D, Sugarman JS, et al. Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions elevated FGF23, and hypophosphatemia. Hum Mol Genet. 2014;23(2):397–407.
Lin AN, Murphy F, Brodie SE, et al. Review of ophthalmic findings in 204 patients with epidermolysis bullosa. Am J Ophthalmol. 1994;118:384–90.
Hammerton ME, Turner TW, Pyne RJ. A case of junctional epidermolysis bullosa (Herlitz-Pearson) with corneal bullae. Austr J Ophthalmol. 1984;12:45–8.
McDonnell PJ, Schofield OMV, Spalton DJ, et al. Eye involvement in junctional epidermolysis bullosa. Arch Ophthalmol. 1989;107:1635–7.
Nakar S, Ingber A, Kremer I, et al. Late-onset localized junctional epidermolysis bullosa and mental retardation: a distinct autosomal recessive syndrome. Am J Med Genet. 1992;43:776.
Gans LA. Eye lesions of epidermolysis bullosa: clinical features, management, and prognosis. Arch Dermatol. 1988;124:762–4.
Signes-Soler I, Rodriguez-Prats JL, Carbonell S, et al. Corneal erosion and Kindler syndrome. Optom Vis Sci. 2013;90(1):e9–10.
El Hachem M, Diociaiuti A, Proto V, et al. Kindler syndrome with severe mucosal involvement in a large Palestinian pedigree. Eur J Dermatol. 2015;25(1):14–9.
Hamada T, McLean WH, Ramsay M, et al. Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1). Hum Mol Genet. 2002;11(7):833–40.
McGrath JA. Lipoid proteinosis. Handb Clin Neurol. 2015;132:317–22.
Vahidnezhad H, Youssefian L, Uitto J. Lipoid proteinosis. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews®. Seattle (WA): University of Washington, Seattle; 2016. p. 1993–2016.
National Institutes of Health Consensus Development Conference Statement. July 13–15, 1987. Neurofibromatosis. https://consensus.nih.gov/1987/1987Neurofibramatosis064html.htm Last accessed 8 Aug 2016.
Hoffman HJ, Humphreys RP, Drake JM, et al. Optic pathway/hypothalamic gliomas: a dilemma in management. Pediatr Neurosurg. 1993;19:186–95.
Yanoff M, Fine BS. Ocular pathology: a text and atlas. 2d ed. Philadelphia: Harper & Row; 1982. p. 33–9.
Little JM, Brownstein S. Ocular neurofibromatosis. Ophthalmology. 1983;91:1595–9.
Goyal JL, Rao VA, Srinivasan R, et al. Oculocutaneous manifestations in xeroderma pigmentosa. Br J Ophthalmol. 1994;78:295–7.
Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum - cutaneous, ocular and neurologic abnormalities in 830 published cases. Arch Dermatol. 1987;123:241–50.
Miller DM, Brodell RT, Levine MR. The conjunctival wart: report of a case and review of treatment options. Ophthalmic Surg. 1994;25:545–8.
Lynch PJ, Minkin W. Molluscum contagiosum of the adult: probably venereal transmission. Arch Dermatol. 1969;98:141–3.
Mathur SP. Ocular complications in molluscum contagiosum. Br J Ophthalmol. 1960;44:572–3.
Lombardo P. Molluscum contagiosum and the acquired immunodeficiency syndrome [letter]. Arch Dermatol. 1985;121:834–5.
Chen X, Anstey AV, Bugert JJ. Molluscum contagiosum virus infection. Lancet Infect dis. 2013;13(10):877–88.
Cotton DWK, Cooper C, Barrett DF, et al. Severe atypical molluscum contagiosum infection in an immunocompromised host. Br J Dermatol. 1987;116:871–6.
Kohn SR. Molluscum contagiosum in patients with the acquired immunodeficiency syndrome [letter]. Arch Ophthalmol. 1987;105:458.
Robinson MR, Udell IJ, Garber PF, et al. Molluscum contagiosum of the eyelids in patients with acquired immune deficiency syndrome. Ophthalmology. 1992;99:1745–7.
Overfield TM, Brody JA. An epidemiologic study of molluscum contagiosum in anchorage. Alaska J Pediatr. 1966;69:640–2.
Torpin R. Amniochorionic mesoblastic fibrous strings and amnion bands: associated constricting fetal malformation or fetal death. Am J Obstet Gynecol. 1965;91:65–75.
Torpin R. Fetal malformations caused by amnion rupture during gestation. Charles C. Thomas: Springfield; 1968.
Seeds JW, Cefalo RC, Herbert WNP. Amniotic band syndrome. Am J Obstet Gynecol. 1982;144:243–8.
Braude L, Miller MT, Cuttone J. Ocular abnormalities in the amniogenic band syndrome. Br J Ophthalmol. 1981;65:299.
BenEzra D, Frucht Y. Uveal coloboma associated with amniotic band syndrome. Can J Ophthalmol. 1983;18:136–8.
Tower P. Coloboma of lower lid and choroid, with facial defects and deformity of hand and forearm. Arch Ophthalmol. 1953;50:333.
Miller MT, Deutsch TA, Cronin C, et al. Amniotic bands as a cause of ocular anomalies. Am J Ophthalmol. 1987;104:270–9.
Canavan TN, Mathes EF, Frieden I, Shinkai K. Mycoplasma pneumonia-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: a systematic review. J Am Acad Dermatol. 2015;72(2):239–45.
Sharma N, Thenarasun SA, Kaur M, et al. Adjuvant role of amniotic membrane transplantation in acute ocular Stevens-johnson syndrome: a randomized control trial. Ophthalmology. 2016;123(3):484–91.
Robert MC, Crnej A, Shen LQ, et al. Infliximab after Boston keratoprosthesis in Stevens-Johnson syndrome: an update. Ocul Immunol Inflamm. 2016;25:1–5. Epub ahead of print. 114.
Barron SJ, Del Vecchio MT, Aronoff SC. Intravenous immunoglobulin in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a meta-analysis with meta-regression of observational studies. Int J Dermatol. 2015;54(1):108–15.
Acknowledgments
The author gratefully acknowledges the original chapter written by Leonard Kristal and Paul J. Honig upon which this chapter revision is based.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Yan, A.C. (2018). Pediatric Dermatology and the Oculoplastic Patient. In: Katowitz, J., Katowitz, W. (eds) Pediatric Oculoplastic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-60814-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-60814-3_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-60812-9
Online ISBN: 978-3-319-60814-3
eBook Packages: MedicineMedicine (R0)